Trientine Tetrahydrochloride (TETA 4HCL) for the Treatment of Wilson's Disease

What is the purpose of this trial?

Brief Summary:

This is a multicenter, randomized, open-label study with an active standard-of-care comparator (penicillamine)


Participation Guidelines

Ages: 18 - 75 years

Gender: Both


gmp-orphan SA

Start Date: 10/10/2018

End Date: 09/30/2019

Last Updated: 10/11/2018

Study HIC#: 2000021684

Get Involved

For more information about this study, contact:
Daksshi Hettiarachchi
+1 203-737-5037
daksshi.hettiarachchi@yale.edu

If you would prefer to contact a member of the Help us Discover team about this trial and other similar trials, please email helpusdiscover@yale.edu or call 1-877-978-8348.

Trial Image

Investigators

Michael Schilsky

Principal Investigator

Sub-Investigators